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Background
The implantation of an mechanical valve in many cases
remains the best treatment option for acquired valve
disease. Mechanical valves, despite necessity of chronic
anticoagulation, has excellent durability and favorable
hemodynamic parameters. The aim of our study was to
evaluate the perioperative mortality in patients under-
going implantation of a mechanical valve and identifying
risk factors of death.
Methods
1500 patients underwent mechanical valve replacement.
The analysis included 960 after aortic (AVR), 455 mitral
(MVR) valve surgery. Mean age in AVR was 58.7 ± 13.0
years and 59.4 ± 9.0 years in MVR. Over 70 years of life in
AVR was 22% and 13% in MVR.
Results
After mechanical aortic valve perioperative mortality was
1.95% (stenosis - 1.9%, insufficiency - 2.4%) and after
mechanical mitral valve was 1.97% (stenosis - 1.6%, insuf-
ficiency- 2.75%). Mortality in the age groups <50 years,
50-60 years, 60-70 years and > 70 years amounted for
mechanical aortic valve 1.6%, 1.0%, 1.7% and 3.2% and
for mechanical mitral valve 1, 8%, 2.8%, 1.8% and 0%
respectively. In patients with aortic stenosis greatest mor-
tality was observed after 70 years (3.0%), similarly in aor-
tic regurgitation (> 70 years - 8.3%). In patients with
mitral stenosis greatest mortality was observed in the
group <50 years (2.9%) and in the case of regurgitation
greatest mortality was observed in group aged 50-
60 years (6.6%). Risk factor for mortality in patients
undergoing implantation of a mechanical aortic valve was
age, severity of symptoms (NYHA), and chronic lung dis-
ease, and mechanical mitral valve - symptoms (NYHA)
and chronic heart failure.
Conclusions
Implantation of artificial aortic or mitral valve is asso-
ciated with a low risk of perioperative death. In the case
of the aortic valve mortality mainly grows with the age of
the patient and in the case of the mitral valve depends on
the development and severity of symptoms of cardiac
failure.
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